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Molecular beacons (MBs) are a novel class of nucleic acid probes that become fluorescent
when bound to a complementary sequence. Because of this characteristic, coupled with the
sequence specificity of nucleic acid hybridization and the sensitivity of fluorescence tech-
niques, MBs are very useful probes for a variety of applications requiring the detection of
DNA or RNA. We survey various applications of MBs, including the monitoring of DNA
triplex formation, and describe recent developments in MB design that enhance their sensi-
tivity.
Introduction
Molecular beacons are fluorescent labeled single-stranded nucleic acid probes that
remain non-fluorescent or weakly fluorescent in a stable stem-loop configuration
bringing a fluorophore in close proximity of a quencher molecule (Fig. 1A) (1).
MBs become strongly fluorescent when the quencher moves away from the donor,
usually upon sequence specific interaction with target nucleic acids or by thermal
dissociation. 
The loop of the MB structure contains the sequence complementary to the target;
Watson-Crick base pairing of 5-6 complementary nucleotides flanking the loop sta-
bilizes the hairpin structure. The fluorescent donor molecule (e.g. fluorescein) and
the acceptor (normally the universal quencher Dabcyl) are attached to the 5’- or 3’-
ends by linker molecules. The design of MBs has been described in detail; see
www.molecular-beacons.org for a comprehensive tutorial.
MBs combine the exquisite sensitivity of fluorescence techniques and the speci-
ficity of nucleic acid sequence recognition and thus are suitable for detecting and
analyzing very small quantities of the target in vitro and in vivo, facilitating specif-
ic targeting in cells and subsequent visualization by sensitive microscopic and
spectroscopic techniques (1,2).
Initial applications of MBs were based on their sequence specific interaction with
single stranded DNA, and included detection of amplified PCR products, muta-
tional analysis, clinical diagnostics, genotyping, and allele discrimination (1-9).
Subsequent studies on the hybridization of MBs with RNAand duplex DNAshowed
that these probes could be very useful for two major approaches of oligonucleotide
therapeutics - anti-sense strategies that depend on translation suppression by form-
ing DNA-RNA hybrids with targeted mRNA (2,10,11), and triplex DNA based anti-
gene strategies that depend on the modulation of gene expression by forming triplex
DNA in the promoter site of targeted genes (12). Further applications of MBs
include the study of DNA-RNA hybridization in real time (2), protein-DNA inter-
actions (13,14), and the kinetics of nucleic acid degradation in presence of nucleas-
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es (15). We present an overview of typical applications of MBs (see also Table 1),
and focus on our use of MBs to study the kinetics of DNA triplex formation.
DNA·DNA hybridization
The formation of duplex DNAby hybridization of the loop sequence of the MB and
its complementary sequence forms the basis of many applications of MBs. Opening
of the hairpin structure of MBs by unwinding of the duplex stem precedes the
hybridization process. The kinetics and thermodynamics of this transition have
been studied in some detail (16,17). An activation energy of +32 kcal/ mol was esti-
mated for the dissociation of the stem formed from CCCAA and its complementa-
ry sequence, with loops of varying lengths. The dissociation rate of the stem was
not affected by the loop size, but decreased with ionic strength. Thermal dissocia-
tion studies using steady state fluorescence techniques showed that the enthalpy
(∆H) and entropy (∆S) for the dissociation of a stem formed from CGCTC and its
complementary target were 34 ± 1 kcal/mol and 104 ± 3 cal/mol•K respectively
(17). The ∆H and ∆S for the dissociation of duplexes formed from a MB (fluores-
cein –5’-CGCTCCCA11CCGAGCG-3-dabcyl’) with perfectly matching sequence
(GGT11GG) were 84 ± 3 kcal/mol and 237 ± 9 cal/mol·K respectively (17). The
corresponding values for the duplex with a single mismatch (5’-GGT5GT5GG-3’)
were 65 ± 3 kcal/mol and 185 ± 10 cal/mol·K, showing a decrease in free energy
(∆G025) by 3.5 kcal/mol, and illustrating the very high sensitivity of MBs for the
detection of DNAmismatches. The structured nature of MBs yields a higher sensi-
tivity for detection of sequence mismatches over a wider range of temperatures
than the corresponding linear probes (17).
Detection of PCR amplification products
Fluorescence based approaches for the detection of PCR products have enhanced
the sensitivity of PCR assays significantly. In one of the earliest applications of
MBs, PCR gene amplification products were quantitated by sequence specific
hybridization of a MB to target DNA (1). AMB with a sequence complementary to
the middle of an 84-nucleotide amplicon was used in a closed PCR reaction tube.
Increasing amplicon concentrations during PCR yielded a fluorescence intensity
enhancement proportional to the different initial concentrations of the target, allow-
ing the monitoring of the PCR reaction in real time. Using MBs with different
donor fluorophores emitting at different wavelengths, the technique has been
extended to a multiplex assay system, enhancing the utility of the approach (3,6).
MBs have also been used to identify amplicons generated in nucleic acid sequence
based amplification (NASBA), the isothermal amplification method (5). Since
PCR amplification precedes many assays, MBs could find increasing use in genet-
ic and biochemical analyses such as genotyping and detection of single nucleotide
polymorphisms.
Genotyping and Allele discrimination
The property of MBs to bind selectively to perfectly matching sequences has been
used for genotyping of human alleles (3,18-20). MBs, each specific to a particular
allele, and each labeled with a distinct fluorophore were used to identify different










































characteristic fluorescence due to the opening of the MB stem, showing that this
method is suitable and very specific for allele discrimination. Mutated alleles of the
β-chemokine receptor (CCR5) with a 32 base deletion were differentiated from
wild-type alleles using two MBs labeled by either fluorescein or tetramethyl rho-
damine (18). These beacons were also used to identify the genotype of the human
DNA samples CCR5 and could distinguish heterozygotes, homozygous wild type,
and homozygous mutants.  Wavelength shifting MBs have been used to distinguish
the ten different genotypes that occur due to the presence of two closely spaced
mutations in this gene (20). Tapp et al compared the ability of MBs and Taqman
probes to distinguish the genotypes arising from three mutations in the human
estrogen receptor gene, and found that these assays were comparable in distin-
guishing the genotypes with C→T and G→A transitions, while MBs performed
better in distinguishing genotypes with C→G transversions (22). 
Clinical Diagnosis 
Coupled with PCR amplification of genes and the capability of real time detection
of hybridization of MBs, methods have been devised to diagnose diseases very sen-
sitively. Since the unbound MB probe is non-fluorescent, it is not necessary to sep-
arate the bound and unbound probes, making the diagnosis relatively simple. Vet et
al. designed an exceedingly sensitive multiplex assay using four different MBs
with four distinct fluorophores and loop sequences specific to HIV-1, HIV-II, and
human lymphotropic viruses types I and II (6). This assay was able to identify 10
copies of a rare retrovirus in 100,000 copies of an abundant virus, and could be per-
formed in a 96 well format in less than 3 hrs. By amplifying a part of the gag gene
sequence of the genome of all currently known HIV-I subtypes (A, B, C and the
circulating recombinant forms AE and AG) subtype specific MBs with multiple
fluorophores were used to distinguish the different forms (9). However, this assay
was not sensitive enough for clinical use. Manganelli et al. used a similar approach
to study the transcript levels of the putative sigma factor genes in Mycobacterium
tuberculosis (21), and to determine the RNAexpression levels after changing exter-
nal parameters like heat shock or low aeration. MBs were also used for the identi-
fication of the opportunistic fungal pathogen Candida dubliniensis (22).
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Figure 1: Schematic representation of molecular
beacons. In its closed form (A), the proximity of the
quencer (yellow) to the fluorophore (green) yeilds a
non-flourescent molecule. The stem of the MB
opens up by thermal dissociation (B) or by hybri-
dazation with single stranded (c) or double stranded
(d) nucleic acids, forming double helical or triple-









































The sequence specific binding of anti-sense oligonucleotides to targeted mRNA as
a means to control translation is a major strategy used in oligonucleotide therapeu-
tics. This approach has been found effective against various neoplasmic and viral
diseases (23-25). MBs with embedded loop sequences complementary to the target
mRNA can be used as anti-sense drugs that report the MB-target hybridization in
real time. Hairpin structured anti-sense oligonucleotides have been used earlier to
study anti-HIV activity (26). These structured probes were found to have higher
sensitivity against DNA degrading enzymes. Steady-state fluorescence studies of
hybridization of a MB targeted to vav proto-oncogene with both a synthetic com-
plementary DNA oligonucleotide and with total cellular mRNA from K562 cells
have been reported (2). The spectral changes were comparable for both targets,
suggesting similar hybridization with DNA and RNA. The same MB was microin-
jected into K562 human leukemia cells allowing real-time visualization of DNA-
RNA hybridization using fluorescence microscopy (2). In the absence of target
molecules, the beacons remain non-fluorescent in living cells; only upon expres-
sion of the specific mRNA do the beacons bind and fluoresce (15-60 fold increase
relative to a control MB), serving as a sensitive monitor of time-dependent gene
expression. This strategy has been developed as an alternative approach in
microscopy to other biosensors such as green fluorescent protein (GFP) (2,4,27).
Arnold et al used MBs to quantitate the expression levels of mRNA for bone mor-
phogenic proteins (responsible for metastasis) in MCF-7 and MDA-MB-231 breast
cancer cell lines after radiation treatment (28). MBs are also useful for studying the
cellular uptake, stability, and binding of different oligonucleotides that are being
developed as drug candidates and for locating target mRNA in the cell (5,10,15). 
In vivo applications have special difficulties associated with them, including degra-
dation of MBs yielding fragments having only fluorophore and no quencher, which
may lead to false results in in vivo hybridization experiments. Moreover, it has been
observed that some MBs open up immediately after entering the cell, probably due
to the lower stability of the stem under cellular ionic conditions (29). A systematic
study of the stability of MBs under various cellular conditions is required.
Analysis of triplex DNA formation
The success of triplex DNA based anti-gene strategies depends on the formation of
stable triplex DNA, usually targeted to the promoter sites of proto-oncogenes (30-
34). Triplex DNA is formed by the binding of the TFO along the major groove of
a duplex DNA target by Hoogsteen or reverse Hoogsteen hydrogen bonds.
Depending on the sequence and orientation of the TFO, three types of triplexes can
be formed – the TC motif (T.A*T, C.G*C+), the GA motif (T.A*A, C.G*G), and
the GT motif (T.A*T and CG*G) (33). Stabilization of the TFO along the major
groove requires stringent conditions such as high ionic strength or the presence of
cationic ligands (35,36).  So far, analysis of triplex DNA using MBs has been
attempted only with GA motifs. Further studies are required to assess the utility of
this approach for the analysis of TC and GT motif triplexes.  
Fluorescence based techniques are being used increasingly for the analysis of
triplex DNA because of the higher sensitivity and ease of experimentation com-
pared to other conventional methods like UV, CD, NMR spectroscopy and elec-
trophoretic mobility shift assay (EMSA). Among the different fluorescence based
approaches, fluorescence polarization and FRET have been shown to be very sen-
sitive and useful in the evaluation of kinetic and thermodynamic parameters under
equilibrium conditions, which is often compromised in methods like EMSA (37-
39). In addition, fluorescence techniques are fast, non-radioactive and nondestruc-
tive in nature. MBs offer an alternative method for the detection of triplex DNA.
The thermodynamics of triplex formation can be analyzed using approaches simi-
lar to those used for duplex formation (17). We have used this approach to 










































proto-oncogene. The beacon used for these studies had a 15-mer loop 
(5’-Fluorescein-CGCTCGAAGGAGGAAGGAGGGAGCG-Dabcyl-3’) designed
to bind specifically to a sequence in the left side of the TC1 tract of the c-Src gene.
As shown in Figure 2, titration of the MB with the target duplex resulted in ~40
fold increase in fluorescence intensity, suggesting triplex DNA formation. Strand
exchange was ruled out since the sequence of  the TFO was  not complementary to
the pyrimidine strand of the duplex. There was no significant increase in fluores-
cence in the presence of a nonspecific duplex, demonstrating sequence specificity
in the interaction of the MB with the target.
The time-dependent enhancement of fluorescence intensity in the presence of the
target duplex was used to analyze the kinetics of triplex formation. The pseudo
first-order rate constants and second-order bimolecular rate constants for the triplex
DNA stabilized by Na+, K+ and Mg 2+ were on the order of 102 s-1and 10-3 M-1s-
1 respectively. The association curves for the binding of MB to target duplex in the
presence of 1 mM MgCl2, 150 mM KCl and 150 mM NaCl at 20 ºC are depicted
in Figure 3. KCl, which is known to inhibit triplex DNA formation in some systems
was found to be more efficient than NaCl in promoting triplex DNA formation
between the MB and the target duplex used in this study. The thermodynamic
analysis showed that the triplex DNA formed in the presence of KCl is entropical-
ly more favorable than that stabilized by NaCl, which may explain the higher asso-
ciation rate of triplex DNA formation in presence of KCl. 
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Figure 2: Fluorescence emission spectra of MB (50
nM) upon titration with target duplex. Conditions:
10mM Sodium Phosphate buffer, pH 7.3, 150 mM
KCl.
Figure 3: Kinetics of triplex DNA formation at 
20 ºC in presence of 1 mM MgCl2, 150 mM KCl and
150 mM NaCl. 5 µM duplex was added to 50 nM
MB in 10 mM Na phosphate buffer, pH 7.3, contain-
ing salt as indicated, and the fluorescence intensity at








































MBs are also useful in evaluating the thermodynamics of triplex DNA formation,
as demonstrated recently in the analysis of binding of an MB with a 21-mer target
sequence in the promoter site of cyclin–D1 stabilized by polyamine homologues
(12). Triplex DNA formation resulted in an enhancement of beacon fluorescence by
12-fold. The variation of fluorescence intensity as a function of duplex concentra-
tion was analyzed for the determination of association constants, which were found
to be ~ 108 M-1 in the presence of 1 mM spermine in 10 mM Na-cacodylate
buffer,pH 7.3, wf∆ and increased ~ 1010 M-1 upon addition of 150 mM NaCl. The
∆H, ∆S and ∆G  values calculated from the temperature dependence of the associ-
ation constant also showed very stable triplex DNA formation in cyclin–D1 gene
promoter site and the utility of using molecular beacons for such analyses.
The formation of triplex DNArequires the dissociation of a stable duplex stem. Thus
triplex DNA formation occurs only when it is thermodynamically more favorable
than stem stabilization. This may limit the use of MBs in triplex DNA formation
studies when the triplex forming sequence is very small or under experimental con-
ditions that stabilize the duplex stem more than the triplex configuration. 
MBs as biosensors 
With the human genome almost completely sequenced, fast and very sensitive
methods for the analysis of genomic data are in great demand. Identifying and
genotyping vast number of genetic polymorphisms in large populations pose a
great challenge. MBs may be very useful molecules for these purposes, particular-
ly for applications like detection of single nucleotide polymorphisms (SNPs). MB
genotyping is emerging as a viable and cost effective method in addition to other
fluorescence based assays like single base extension with fluorescence detection,
homogeneous solution hybridization and oligonucleotide ligation assay (18,40,41).
Tan et al. developed a MB based biosensor for the analysis of RNA and DNA using
a biotinylated beacon surface immobilized on optical fibers (42,43). The enhance-
ment of fluorescence after dipping in solutions containing gamma-actin mRNA
amplified by PCR was analyzed and the concentration detection limit of this MB
evanescent wave biosensor was found to be as low as 1.1 nM.
Recent developments in molecular beacons
Scorpion primers – Scorpion primers were developed to detect specifically the PCR
amplification products in high throughput and automated methods. They have a basic
MB design with a primer attached to the 3’-end. The heating and cooling (annealing)
step after primer extension leads to binding of the loop to the sequence extended by PCR
in a unimolecular mechanism. This binding leads to opening of the hairpin structure and
a corresponding increase in fluorescence. Comparison with MB and Taqman polymer-
ization methods showed that this is a superior method particularly under fast cycling con-
ditions, under which hybridization is probably kinetically controlled (44,45). A major
advantage of this method in PCR reactions is that scorpion primers have a PCR stopper
that connects the loop and the 5’end, preventing the detection of non-specific PCR prod-
ucts.  Development of a cystic fibrosis mutation detection assay using this method
showed that scorpion primers are selective enough to detect single mutations and gave
good sensitivity in all cases.  Using scorpion primers with different fluorophores, this
assay has been extended to a multiplex assay.
Wavelength shifting MBs – In a very recent development, Tyagi et al developed
wavelength-shifting MBs that couple both the quenching and FRET mechanisms
(19). In addition to the donor (termed as harvester fluorophore) and the quencher,
another fluorophore that is a FRET acceptor (termed as emitter fluorophore) for the
donor molecule, is attached through a spacer oligonucleotide.  In the absence of tar-
get oligonucleotide, the molecule remains non-fluorescent due to the quenching of
fluorescence as in the conventional MB. In the presence of a sequence specific tar-
get, the stem opens up, the quencher moves away, and the harvester fluorophore










































efficient FRET. A major advantage of this approach is that a single harvester fluo-
rophore can be combined with different emitter fluorophores, allowing excitation
at a single wavelength for different beacons targeted to bind to different sequences.
This is particularly important for imaging applications where a single wavelength
laser source is used. The application of this method has been demonstrated using
wavelength shifting MBs with fluorescein as harvester fluorophore and  6-car-
boxyrhodamine 6G, tetramethylrhodamine or Texas red as the emitter fluorophore.
Comparison of the hybridization to the targets of these wavelength-shifting MBs
with conventional MBs showed significantly higher signal strength for the former
showing the superiority of this approach. Its application in real time PCR and for
the detection of two single nucleotide polymorphisms that occur very close to each
other has also been demonstrated. 
MBs with gold nanoparticles as quenchers – Recent developments in the assembly of
hybrid materials composed of biomolecules and nonbiological, inorganic objects have
been used to enhance the detection sensitivity of MBs further. Nanoparticles have been
used as the quencher instead of the commonly used Dabcyl, whose quenching efficien-
cy is lower for dyes emitting at longer wavelengths. Dubertret et al. developed a MB
with a 1.4 Å gold nanoparticle that quenches fluorescein fluorescence by non-radiative
energy transfer as much as 100 times more efficiently than Dabcyl (46). Comparison of
the hybridization of MBs with gold nanoparticles and conventional MBs showed that the
former are more sensitive for mismatch detection. These hybrid MBs are postulated to
be more useful in detecting minute quantities of oligonucleotides in a pool of random
sequences and for improved detection of single mismatches.
Summary
The applications described above show that MBs have become very important
tools for a large number of biological applications. In the post genomic era, high
throughput and low cost genetic analysis is expected to be crucial in the detection
of various genetic diseases and to monitor the response to drug treatment. MBs
with extremely high sensitivity and specificity will be very useful probes for many
of these analyses. The possibility of using beacons in micro arrays to analyze a
large number of samples simultaneously has already been demonstrated. With sig-
nificant advances in fluorescence imaging techniques, MBs may find increasing
applications in the study of localizing DNA and RNA, in understanding their
dynamics in the cellular environment, and in tracking biochemical changes after
blocking the transcription or translation with antisense oligonucleotides.
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